Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review

Immunotherapy has radically changed the clinical management of patients with cancer in recent years. Immune checkpoint inhibitors (ICIs) reversing the immunosuppressive effects of the tumor microenvironment are one type of immunotherapy, several of which are approved by the US Food and Drug Administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Wu-Yan, Feng, Wen, Zhang, Chen-Chen, Shen, Yu-Jia, Zhang, Qin, Yu, Wen, Cai, Xu-Wei, Fu, Xiao-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653139/
https://www.ncbi.nlm.nih.gov/pubmed/33209631
http://dx.doi.org/10.21037/tlcr-20-827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653139/
https://www.ncbi.nlm.nih.gov/pubmed/33209631
http://dx.doi.org/10.21037/tlcr-20-827

Ejemplares similares